Efficacy and clinicogenomic biomarkers of response to dual versus single agent checkpoint inhibitor therapy in untreated metastatic non-small cell lung cancer Meeting Abstract
| Authors: | Boiarsky, D.; Hong, L.; Ricciuti, B.; Cooper, A. J.; Saad, M. B.; Elkrief, A.; Di Federico, A.; Aminu, M.; Rinsurongkawong, W.; Lewis, J.; Gibbons, D. L.; Vaporciyan, A. A.; Le, X.; Lee, J. J.; Heymach, J.; Wu, J.; Schoenfeld, A. J.; Awad, M. M.; Zhang, J.; Vokes, N. I. |
| Abstract Title: | Efficacy and clinicogenomic biomarkers of response to dual versus single agent checkpoint inhibitor therapy in untreated metastatic non-small cell lung cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402047 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8549 |
| Notes: | Meeting Abstract: 8549 -- Source: Wos |
